BiVictriX Therapeutics (BVX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.33p
   
  • Change Today:
    -0.17p
  • 52 Week High: 15.90
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 82.53m
  • Volume: 0
  • Market Cap: £9.35m

Regulatory News

Orphan Drug Designation & FDA INTERACT Meeting 17-Apr-2024 07:00 RNS
Grant of Options – PDMR/Direc... 28-Mar-2024 07:00 RNS
Holding(s) in Company 04-Jan-2024 12:30 RNS
Holding(s) in Company 04-Jan-2024 12:30 RNS
BiVictriX Hosts Inaugural Roundtable Discussion 04-Jan-2024 07:00 RNS
Board Change 05-Dec-2023 11:08 RNS
Pipeline update on BVX002 30-Nov-2023 07:00 RNS
Holding(s) in Company 22-Nov-2023 17:14 RNS
Patent Granted in Japan 15-Nov-2023 07:00 RNS
Extended Survival Rates Reported with BVX001 12-Oct-2023 07:00 RNS
Appointment of Adrian Howd as CFO and CBO 03-Oct-2023 07:00 RNS
Interim Results 19-Sep-2023 07:00 RNS
Total Voting Rights 31-Aug-2023 07:00 RNS
US Patent Granted 23-Aug-2023 07:00 RNS
Holding(s) in Company 17-Aug-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BVX Market Data

Currency UK Pounds
Share Price 11.33p
Change Today -0.17p
% Change -1.45 %
52 Week High 15.90
52 Week Low 10.50
Volume 0
Shares Issued 82.53m
Market Cap £9.35m

BVX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.38% below the market average51.38% below the market average51.38% below the market average51.38% below the market average51.38% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average
Price Trend
60.37% below the market average60.37% below the market average60.37% below the market average60.37% below the market average60.37% below the market average
12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average
Income Not Available
Growth Not Available

BVX Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

BVX Key Personnel

CEO Tiffany Jane Thorn

Top of Page